Cancer Communications
indexed by SCI
BMC

[ Special series on U ]
doi: 10.1186/s40880-017-0194-7
Ailanthone: a new potential drug for castration-resistant prostate cancer
Shihong Peng, Zhengfang Yi and Mingyao Liu
East China Normal University and Shanghai Fengxian District Central Hospital Joint Center for Translational Medicine, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University
Chinese Journal of Cancer 2017, Volume: 36, Issue 5
[ PDF Full-text ]
[ Html full-text / Citation export] (BioMed Central)

[Google Scholar]


[ More articles of the special series on U ]


Cite this article

Shihong Peng, Zhengfang Yi and Mingyao Liu. Ailanthone: a new potential drug for castration-resistant prostate cancer. Chin J Cancer. 2017, 36:25. doi:10.1186/s40880-017-0194-7


Export citations

EndNote


SHARE THIS ARTICLE


Your Comments

  

 


Comments:


CJC Wechat 微信公众号

CJC触屏版


 

Editorial Manager


CC adopts Editorial Manager to manage its submissions from Dec.18, 2014
 

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CJC is now published by BioMed Central

© Chinese Journal of Cancer

Sun Yat-sen University Cancer Center

651 Dongfeng Road East, Guangzhou 510060, P. R. China